IBD: The late repercussions of early antibiotics use

Image source: Scientific Illustrations, Inc. (CC BY-SA 4.0)

News • Right in the guts

IBD: The late repercussions of early antibiotics use

Disruption of gut bacteria by antibiotics soon after birth can affect the maturation of the immune system, say researchers at Rutgers University-New Brunswick.

Even short, single antibiotic courses given to young animals can predispose them to inflammatory bowel disease (IBD) when they are older, according to their research. The study, published in Genome Medicine, provides further evidence supporting the idea that the use of antibiotics in children under 1 year old disrupts the intestinal microbiota – the trillions of beneficial microorganisms that live in and on our bodies – that play a crucial role in the healthy maturation of the immune system and the prevention of diseases, such as inflammatory bowel disease and type 1 diabetes.

Recommended article

“This study provides experimental evidence strengthening the idea that the associations of antibiotic exposures to the later development of disease in human children are more than correlations, but that they are actually playing roles in the disease causation,” said study co-author Martin Blaser, director of the Rutgers Center for Advanced Biotechnology and Medicine.

The use of a well-validated model of colitis enabled us to study the effects of prior antibiotic exposures on the development of an important disease process

Ceren Ozkul

To determine if the increased disease risk was due to the disruption of the microbiome from antibiotics, the researchers studied the effects of exposure to dextran sulfate sodium, a chemical known to injure the colon, both in mice that received antibiotics, and in mice that had perturbed microbial contents transplanted into their intestines versus a control group. They found that the mice that received either the antibiotics themselves or received the antibiotic-perturbed microbiome had significantly worse colitis, showing that exposure to antibiotics changed the microbiome, altered the immune response in the colon and worsened the experimental colitis. “The use of a well-validated model of colitis enabled us to study the effects of prior antibiotic exposures on the development of an important disease process," said lead author Ceren Ozkul, a visiting scholar from the Department of Pharmaceutical Microbiology at Hacettepe University in Turkey.

The study continues Blaser’s work on the hypothesis that disrupting the early life microbiome, especially by antibiotics and C-section, is one of the factors driving modern epidemics.


Source: Rutgers University-New Brunswick.

29.07.2020

Read all latest stories

Related articles

Photo

News • Increasing prevalence

Oral antibiotics may raise risk of kidney stones - especially in kids

Pediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones. This is the first time that these medicines…

Photo

News • A chatbot to replace GPs?

ChatGPT does a surprisingly solid job at prescribing the right meds, but...

Researchers from the University of Liverpool have tested whether the AI-powered chatbot ChatGPT could be used to make decisions about prescribing patients with antibiotics.

Photo

News • Drug delivery research

'Tunneling' capsule to enable oral insulin intake

A newly developed capsule that tunnels through mucus in the GI tract could be used to orally administer large protein drugs such as insulin.

Related products

Calypso F – Multifunctional DR system

DR

GMM Group · Calypso F – Multifunctional DR system

General Medical Merate S.p.A. (GMM Group)
DRG Instruments · DRG:Hybrid-XL

Immunochemistry

DRG Instruments · DRG:Hybrid-XL

DRG Instruments GmbH
Fujifilm Wako · Autokit Total Ketone Bodies Assay

Clinical Chemistry

Fujifilm Wako · Autokit Total Ketone Bodies Assay

FUJIFILM Wako Chemicals Europe GmbH
Opera Sharp Evolution – Remote-controlled system

Flatpanel Fluoro

GMM Group · Opera Sharp Evolution – Remote-controlled system

General Medical Merate S.p.A. (GMM Group)
Subscribe to Newsletter